Last reviewed · How we verify
NCT05742737
Frailty Index as An Indicator Associated With Postoperative Adverse Outcomes In The Older Population
trial testing Frailty Index in Frailty in 12,000 participants. Completed in 1 April 2023.
30 April 2022
Quick facts
| Lead sponsor | Weidong Mi |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 12,000 |
| Start date | 1 April 2020 |
| Primary completion | 30 April 2022 |
| Estimated completion | 1 April 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Frailty Index
Conditions studied
- Frailty — all drugs for Frailty →
Sponsor
Weidong Mi
Who can join
65 and older, any sex, with Frailty. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a observational study in China, which aims to explore the predictive effect of preoperative frailty defined by the modified frailty index in predicting postoperative survival and complications in elderly patients. The objectives of the study include: 1\. To demonstrate that the frailty scale can predict short- and long-term survival after surgery in elderly surgical patients; 2 Demonstrated that frailty as defined by this scale is associated with postoperative complications in older patients
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05742737
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Frailty
Currently open trials in the same condition.
- NCT07481188 — Frailty and Nottingham Hip Fracture Score for Predicting 90-Day Mortality After Hip Fracture Surgery · recruiting
- NCT07519603 — Frailty in Older Adults With Chronic Obstructive Pulmonary Disease (COPD) and Outcomes of the VIVIFRAIL Program · NA · recruiting
- NCT07144527 — Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults · NA · recruiting
- NCT07392944 — Multicomponent Exercise Program on Physical Function, Cognition and Falls Risk Among Older Adults Living in Nursing Home · NA · recruiting
- NCT07475767 — Ultrasound Indicators of Nutritional Status and Treatment Outcomes in Surgical Patients in the Intensive Care Unit · recruiting
Other Weidong Mi trials
Trials by the same sponsor.
- NCT06612177 — Elderly Patients Surgical Site Infection Phenotypes Identification · completed
- NCT06547281 — Machine Learning Prediction of Multiple Infections in Elderly Surgical Patients · completed
- NCT06265493 — Postoperative Infectious Complications Calculator for Elderly Patients · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05742737 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Weidong Mi
- Last refreshed: 10 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05742737.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing